Table 21. Secondary mitral regurgitation: Recommendations1,2,53,57–72.
| Intervention | Clinical condition | SBC | AHA | ESC |
|---|---|---|---|---|
| Mitral valve replacement or repair | Ischemic | |||
| Symptomatic (NYHA FC ≥ III) Associated revascularization |
IIb B | IIb B | IIb C | |
| IIa B | IIa B | I C (LVEF > 30%) IIa C (LVEF < 30%) |
||
| Dilated | ||||
| Symptomatic (NYHA FC ≥ III) | IIb B | IIb B | IIb C | |
| Percutaneous mitral valve repair | Ischemic | |||
| Refractory symptoms (NYHA FC ≥ III), with high risk or contraindication to surgery | IIa B | – | IIb C (LVEF < 30%) |
|
| Dilated | ||||
| Refractory symptoms (NYHA FC ≥ III) with high risk or contraindication to surgery | IIa B | – | IIb C (LVEF < 30%) |
AHA: American Heart Association; ESC: European Society of Cardiology; FC: functional class; LVEF: left ventricular ejection fraction; SBC: Sociedade Brasileira de Cardiologia (Brazilian Society of Cardiology).